CAS 215647-85-1
:Peginterferon alfa-2b
Description:
Peginterferon alfa-2b is a modified form of interferon alfa-2b, which is a type of protein used in the treatment of various viral infections and certain types of cancer. It is characterized by the addition of polyethylene glycol (PEG) molecules, which enhance its stability and prolong its half-life in the bloodstream, allowing for less frequent dosing compared to unmodified interferons. This substance exhibits antiviral, antiproliferative, and immunomodulatory properties, making it effective in the treatment of chronic hepatitis C and some malignancies. Peginterferon alfa-2b works by binding to specific receptors on the surface of cells, triggering a cascade of immune responses that inhibit viral replication and enhance the immune system's ability to fight infections. It is typically administered via subcutaneous injection. Common side effects may include flu-like symptoms, fatigue, and changes in blood cell counts. As with any medication, its use should be closely monitored by healthcare professionals to manage potential adverse effects and ensure therapeutic efficacy.
Formula:Unspecified
Synonyms:- Interferon α-2b (human), pegylated
- Peginterferon alfa-2b
- PegIntron
- Sch 54031
- ViraferonPeg
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
Peginterferon alfa-2b
CAS:<p>Peginterferon alfa-2b (Sch 54031) is a PEGylated immunomodulator used in HIV and melanoma research.</p>Color and Shape:Solid
